It has been suggested that activation of PERK may be responsible for cognitive deficiencies in AD (Duran-Aniotz et al., 2014) by altering active protein synthesis through modulation of eIF2α phosphorylation (Costa-Mattioli et al., 2005, 2009; Jiang et al., 2010). This evidence concerns the gene EIF2A and Alzheimer disease.